Hemolytic Transfusion Reaction (HTR)
What is Hemolytic Transfusion Reaction (HTR)?
Hemolytic transfusion reaction is a serious complication that can happen after receiving a blood transfusion. Your immune system attacks the donated red blood cells because it sees them as foreign invaders. This reaction happens when the blood type you receive does not match your own blood type properly.
There are two main types of hemolytic transfusion reactions. Acute reactions happen within 24 hours of the transfusion and can be life threatening. Delayed reactions occur days or weeks after the transfusion and tend to be less severe. Both types cause the destruction of red blood cells, which is called hemolysis.
Modern blood banking practices have made these reactions rare. Careful blood typing and crossmatching before transfusions help prevent most cases. When reactions do occur, they need immediate medical attention. Understanding your blood type and transfusion history helps medical teams keep you safe.
Symptoms
- Fever and chills during or shortly after transfusion
- Back pain or chest pain
- Dark urine, often brown or red in color
- Rapid heart rate
- Low blood pressure
- Shortness of breath or difficulty breathing
- Nausea and vomiting
- Anxiety or feeling of impending doom
- Jaundice, which is yellowing of the skin and eyes
- Decreased urine output or kidney problems
Delayed hemolytic transfusion reactions may cause milder symptoms that develop gradually. Some people experience only mild fever and anemia. Early recognition of symptoms during transfusion allows medical teams to stop the process immediately.
Concerned about Hemolytic Transfusion Reaction (HTR)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Hemolytic transfusion reactions happen when there is a mismatch between donor and recipient blood. The most common cause is human error in blood typing or labeling samples. ABO incompatibility causes the most severe acute reactions. This occurs when someone receives blood from the wrong ABO blood group. Your immune system has natural antibodies against blood types you do not have.
Delayed reactions often occur in people who received transfusions or were pregnant in the past. Their immune system developed antibodies against minor blood group antigens. These antibodies may not show up on routine screening tests. When exposed to the same antigen again through transfusion, the immune system mounts a response. People who need frequent transfusions face higher risk of developing these antibodies over time.
How it's diagnosed
Diagnosis begins immediately if symptoms occur during or after a transfusion. Medical staff will stop the transfusion right away and check all blood labels and patient identification. Blood samples from both you and the donor unit are sent for testing. An antibody screen can detect antibodies that may be attacking the transfused red blood cells.
Laboratory tests check for signs of red blood cell destruction. These include measuring free hemoglobin in your blood and urine. A direct antiglobulin test, also called a Coombs test, looks for antibodies coating your red blood cells. Your kidney function is monitored closely because damaged red blood cells can harm your kidneys. Talk to your doctor about specialized testing if you have had transfusion reactions in the past.
Treatment options
- Immediate discontinuation of the blood transfusion
- Intravenous fluids to support blood pressure and protect kidney function
- Medications to manage fever and pain
- Oxygen therapy if breathing is affected
- Dialysis in severe cases with kidney failure
- Blood pressure medications if needed
- Close monitoring in a hospital setting
- Identification of the antibody causing the reaction for future transfusions
- Maintaining detailed transfusion records for future medical care
- Wearing medical alert identification if you have rare antibodies
Frequently asked questions
Hemolytic transfusion reactions are rare due to modern blood banking safety protocols. Acute reactions occur in about 1 in 70,000 transfusions. Delayed reactions happen more frequently, in roughly 1 in 2,500 transfusions. Most reactions today are mild, and severe cases are extremely uncommon.
Yes, careful screening and matching procedures prevent most reactions. Blood banks perform ABO and Rh typing on all donors and recipients. Crossmatching tests mix your blood with donor blood before transfusion. Antibody screening identifies unusual antibodies that could cause problems. Proper patient identification at every step is critical.
Anyone can experience a reaction if given incompatible blood. People with type O blood have antibodies against A and B antigens, making them vulnerable if given wrong blood. People who have been pregnant or received multiple transfusions may develop antibodies to rare blood antigens. Keeping detailed medical records helps prevent these issues.
Acute hemolytic reactions typically start within minutes to hours of transfusion. Symptoms often appear when only a small amount of blood has been given. Delayed reactions develop 3 to 14 days after transfusion. These delayed reactions are usually less severe but still require medical evaluation.
Acute reactions happen within 24 hours and involve antibodies already present in your blood. They tend to be more severe and life threatening. Delayed reactions occur days to weeks later when your immune system produces new antibodies against the transfused blood. These are usually milder but can still cause anemia and jaundice.
Yes, but special precautions are necessary. Your medical team will identify which antibodies caused your reaction. Future transfusions will use blood that lacks those specific antigens. You should carry a card or wear a medical alert bracelet noting your antibody status. Blood banks keep records of your antibody history.
Your immune system attacks and destroys the transfused red blood cells. This releases hemoglobin into your bloodstream, which can damage your kidneys. The rapid breakdown of red blood cells causes inflammation throughout your body. Your body may struggle to maintain normal blood pressure and organ function during severe reactions.
People who receive frequent transfusions face the highest risk. This includes individuals with sickle cell disease, thalassemia, or certain cancers. Women who have been pregnant multiple times may develop antibodies from fetal blood exposure. People with autoimmune conditions may also be more prone to developing these antibodies.
An antibody screen is a blood test that looks for unexpected antibodies in your blood. These antibodies could attack transfused red blood cells. The test is performed before any planned transfusion or surgery. It helps identify people who need specially matched blood to prevent reactions.
Most people recover fully with prompt treatment. Severe reactions can cause lasting kidney damage in some cases. Your immune system will remember the antibodies it produced, affecting future transfusions. You will need specially matched blood for any future transfusions. Keeping detailed medical records prevents repeat reactions.